Market Highlights: The tests used for diagnosing the different diseases such as dengue, hepatitis, HIV, measles, rabies, and others referred to viral disease diagnosis. Increasing number of patients with the above diseas...
“The Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) regulates human cells, tissues, and cellular and tissue-based products (HCT/P) intended for implantation, transplantation, infusion ...
According to the report, Growing Incidence of Various Animal Diseases
is one of the primary growth factors for the market. Increase in the Adoption of Pet and Livestock Animals
is also expected to contribute signifi...
AdvanceMarketAnalytics, a global market research and consulting organization, have released a new study titled "DNA 3D Printing market - Global outlook to 2024". Industries constant focus on reducing the operational cos...
“According to Food and Drug Administration (FDA), each party engaged in the manufacture of a drug is responsible for ensuring compliance with Current Good Manufacturing Practice regulations (CGMP) for the manufacturing a...
Global Healthcare Chatbots are expected to make a significant contribution to the overall industry, with an estimated market to reach USD315.18 Million by 2024. According to the report, some of the important driving forc...
AdvanceMarketAnalytics, a global market research and consulting organization, have released a new study titled "Biologics and Biosimilars market - Global outlook to 2024". Industries constant focus on reducing the opera...
Global Life Science Instrumentation are expected to make a significant contribution to the overall industry. According to the report, some of the important driving forces behind the market growth are “Increasing Spe...
AdvanceMarketAnalytics, a global market research and consulting organization, have released a new study titled "PCR Reagent market - Global outlook to 2024". Industries constant focus on reducing the operational cost an...
“The FDA’s Center for Drug Evaluation and Research, or CDER, is the specific body within the FDA that is involved with reviewing the new drug development process. The CDER has in-depth understanding of the science used t...
